rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    DNA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Is Anthropic’s IPO a Good Reason to Buy Ginkgo Bioworks Right Now? | The Motley Fool

      The AI developer's offering will give it a pile of cash that it might choose to spend on biomedical research automation.

      3h agoThe Motley FoolDNA
      Ginkgo Bioworks director Christian O. Henry sells $35,405 in shares
      Nov 15Investing.comDNA
      Ginkgo Bioworks Holdings Inc (DNA) Q3 2026 Earnings Call Highlights: Cost Cuts, First Big ...
      Nov 12Yahoo FinanceDNA
      Ginkgo Bioworks: 3 Key Takeaways for Long-Term Investors
      Nov 7Yahoo FinanceDNA
      Ginkgo Bioworks Q3 Earnings Call Highlights
      Nov 7Yahoo FinanceDNA
      Ginkgo Bioworks Holdings, Inc. Q3 2026 Earnings Call Summary
      Nov 6Yahoo FinanceDNA
      Ginkgo Bioworks earnings beat by $0.37, revenue topped estimates
      Nov 5Investing.comDNA
      Ginkgo Bioworks Reports Third Quarter 2026 Results; Signs First Autonomous Lab Sale to a Top-Tier Pharma Company Novo
      Nov 5Yahoo FinanceDNA
      Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key Insights
      Oct 29Yahoo FinanceDNA
      What Ginkgo Bioworks Bears Saw Before The Fall
      Oct 24Yahoo FinanceDNA
      Ginkgo Bioworks CEO Jason Kelly sells $463,352 in shares
      Oct 21Investing.comDNA
      Ginkgo Bioworks president and founder Shetty sells $417,607 in shares
      Oct 21Investing.comDNA
      Ginkgo Bioworks CFO Steven Coen sells $7,769 of company stock
      Oct 21Investing.comDNA
      Ginkgo Bioworks director Barry Canton sells $417,607 in stock
      Oct 21Investing.comDNA
      Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know

      Ginkgo Bioworks Holdings, Inc. (DNA) reached $9.86 at the closing of the latest trading day, reflecting a -2.09% change compared to its last close.

      Oct 20Yahoo FinanceDNA
      Ginkgo Bioworks (DNA) Stock Fair Value Edges Higher After Analysts Reassess AI Demand
      Oct 14Yahoo FinanceDNA
      Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
      Oct 14Yahoo FinanceDNA
      What's Going on With Ginkgo Bioworks Stock on Friday? - Ginkgo Bioworks Holdings (NYSE:DNA)

      Ginkgo Bioworks offers remote autonomous lab access to NSF X-Labs and integrates Araceli imaging into its Boston platform.

      Oct 9BenzingaDNA
      Ginkgo Bioworks to support NSF X-Labs with lab access
      Oct 8Investing.comDNA
      Ginkgo Bioworks to Provide Lab Access to NSF X-Labs Researchers
      Oct 8Yahoo FinanceDNA
      Ginkgo Bioworks, Araceli Biosciences Add Cellular Imaging to Autonomous Lab
      Oct 8Yahoo FinanceDNA
      Ginkgo Bioworks integrates Araceli imaging system into lab
      Oct 8Investing.comDNA
      Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop
      Oct 8MorningstarDNA
      Ginkgo Bioworks CFO Steven Coen sells $36,045 in stock
      Oct 7Investing.comDNA
      Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know

      Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $11.47, moving 7.57% from the previous trading session.

      Oct 7Yahoo FinanceDNA
      Ginkgo Bioworks: The Valuation Has Outrun The Business (NYSE:DNA)

      Ginkgo Bioworks (DNA) reiterates a Sell: AI/biotech hype vs weak fundamentals, commoditized TuneLab, plunging revenue & cash burn risks—read now.

      Oct 7Seeking AlphaDNA
      Ginkgo Bioworks Holdings stock hits 52-week high at 17.62 USD
      Oct 6Investing.comDNA
      This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled

      Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

      Oct 5The Globe and MailDNA
      Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know

      In the closing of the recent trading day, Ginkgo Bioworks Holdings, Inc. (DNA) stood at $12.5, denoting a -2.57% move from the preceding trading day.

      Oct 1Yahoo FinanceDNA
      Ginkgo Bioworks: Another Curious Rally (NYSE:DNA)

      Ginkgo Bioworks surged on partnership news, but Q2 revenue fell and losses widened as valuation jumps. Click here to read this DNA stock update.

      Sep 29Seeking AlphaDNA
      Ginkgo Bioworks Holdings, Inc. (DNA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
      Sep 23Yahoo FinanceDNA
      Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?

      Ginkgo Bioworks (DNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

      Sep 18Yahoo FinanceDNA
      Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts

      Ginkgo Bioworks Holdings, Inc. (DNA) concluded the recent trading session at $7.06, signifying a +1% move from its prior day's close.

      Sep 16Yahoo FinanceDNA
      Twist Bio, Gingko rise on Lilly TuneLab deals (TWST:NASDAQ)

      Twist Bioscience (TWST) stock and Ginkgo Bioworks (DNA) stock gain as companies ink agreements with Eli Lilly’s (LLY) TuneLab R&D platform. Read more here.

      Sep 16Seeking AlphaTWSTDNALLY
      Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data

      BOSTON, September 16, 2026--Ginkgo Bioworks (NYSE: DNA) today announced that its Ginkgo Datapoints offering has entered into a new agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). TuneLab supports biotech innovation by enabling participating companies to access AI/ML drug discovery models trained on decades of Lilly's proprietary research data.

      Sep 16Yahoo FinanceDNA
      Twist Bio, and Ginkgo rise after agreements with Lilly TuneLab (TWST:NASDAQ)
      Sep 16Seeking AlphaTWSTDNALLY
      Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines

      BOSTON, September 10, 2026--Ginkgo Bioworks (NYSE: DNA) today announced that it has been awarded a subcontract for up to $17.5M under the Advanced Research Projects Agency for Health’s (ARPA-H) Genetic Medicines and Individualized Manufacturing for Everyone (GIVE) program. Ginkgo will serve as a subcontractor to prime contractor Waterfall Scientific, Inc. on ESCALATOR (Engineering a Small-scale, Continuous-flow manufacturing Apparatus to Launch A Transformational Overhaul for RNA medicines), a m

      Sep 10Yahoo FinanceDNA
      BTIG cuts Ginkgo Bioworks stock price target on transition concerns
      Sep 9Investing.comDNA
      BTIG reiterates Ginkgo Bioworks stock Sell rating at $5 target
      Sep 4Investing.comDNA
      Ginkgo Bioworks: Another Pivot, Still No Proof Of Product-Market Fit (NYSE:DNA)
      Sep 1Seeking AlphaDNA
      Ginkgo Bioworks CFO Steven Coen sells $2,302 in stock
      Aug 25Investing.comDNA

      This is the newest page. Registered accounts read further back.